{"context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}], "author_id": "29654415", "reply_settings": "everyone", "public_metrics": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}, "lang": "en", "possibly_sensitive": false, "conversation_id": "1240877150468743168", "created_at": "2020-03-20T07:44:39.000Z", "source": "Twitter Web App", "id": "1240907089373007872", "entities": {"mentions": [{"start": 0, "end": 9, "username": "DrTedros", "id": "189868631"}]}, "referenced_tweets": [{"type": "replied_to", "id": "1240877150468743168"}], "in_reply_to_user_id": "189868631", "text": "@DrTedros Source: European Society of Cardiology. Researchers suggest that ACEis and ARBs medications may be protective against COVID-19 and are potential treatments of the infection. Randomized controlled trials are currently in development"}